Fact Sheet

Name

Bioxyne Limited Business

Description

Bioxyne Limited (ASX:BXN) is an international Australian life sciences company headquartered in Sydney, and parent company of the Breathe Life Sciences Group. Bioxyne and wholly owned subsidiary Breathe Life Sciences manufacture and distribute novel medicines (cannabis, MDMA, Psilocybin) and consumer health products (CBD, functional mushrooms, other) in Australia, Europe, UK, Japan, and USA. In Australia, Breathe Life Sciences holds a TGA manufacturing license, controlled substance licenses to import, export, and wholesale Schedule 3,4, 8 and 9 products, operating primarily business to business. Outside of Australia, the business has manufacturing and distribution centres in Japan, the UK, and Europe, and operates direct to consumer supply of its trademarked Dr Watson® brand. For more information on Bioxyne, please visit https://bioxyne.com

Shares on Issue

Ordinary shares: 2,053,312,000
Performance Rights 26,666,667

Listings

ASX

Managing Director and Chief Executive Officer

Mr Samuel Watson

Chief Financial Officer

Guy Robertson

Board of Directors

Mr Anthony Ho – Non Executive Chairman
Mr Samuel Watson – Managing Director and CEO
Jason Hine – Executive Director
Company Secretary: Guy Robertson

Registered Office

Suite 506, Level 5 50 Clarence Street Sydney NSW 2000
Phone: + 61 2 9078 8180
Fax: +6102 9078 7661
Email: info@bioxyne.com
Web: http://www.bioxyne.com

Share Registry

Automic Pty Ltd Level 5 126 Phillip Street Sydney NSW 2000
Phone: 1300 288 664
Fax: +61 2 9698 5414
Email: hello@automicgroup.com.au
Web: www.securitytransfer.com.au

Auditor

RSM Australia Partners Level 13, 60 Castlereagh Street Sydney NSW 2000
Phone: +61 2 8226 4500